• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液神经胶质生物标志物 YKL40 和 sTREM2 与认知正常个体的纵向体积和弥散度变化相关。

CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals.

机构信息

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain; CIBER-BBN, Madrid, Spain.

Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

出版信息

Neuroimage Clin. 2019;23:101801. doi: 10.1016/j.nicl.2019.101801. Epub 2019 Apr 1.

DOI:10.1016/j.nicl.2019.101801
PMID:30978656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6458453/
Abstract

Cerebrospinal fluid (CSF) YKL40 and sTREM2 are astroglial and microglial activity biomarkers, respectively. We assessed whether CSF YKL40 and sTREM2 baseline levels are associated with longitudinal brain volume and diffusivity changes in cognitively unimpaired adults. Two brain MRI scans of 36 participants (57 to 78-years old, 12 male) were acquired in a 2-year interval. Aβ, p-tau, YKL40 and sTREM2 concentrations in CSF were determined at baseline. We calculated gray and white matter volume changes per year maps (ΔGM and ΔWM, respectively) by means of longitudinal pairwise registration, and mean diffusivity variation per year (ΔMD) by subtraction. We checked voxel-wise for associations between ΔGM, ΔWM and ΔMD and baseline CSF level of YKL40 and sTREM2 and verified to what extent these associations were modulated by age (YKL40xAGE and sTREM2xAGE interactions). We found a positive association between ΔGM and YKL40 in the left inferior parietal region and no association between sTREM2 and ΔGM. Negative associations were also observed between ΔGM and YKL40xAGE (bilateral frontal areas, left precuneus and left postcentral and supramarginal gyri) and sTREM2xAGE (bilateral temporal and frontal cortex, putamen and left middle cingulate gyrus). We found negative associations between ΔWM and YKL40xAGE (bilateral superior longitudinal fasciculus) and sTREM2xAGE (bilateral superior longitudinal fasciculus, left superior corona radiata, retrolenticular external capsule and forceps minor, among other regions) but none between ΔWM and neither YKL40 nor sTREM2. ΔMD was positively correlated with YKL40 in right orbital region and negatively with sTREM2 in left lingual gyrus and precuneus. In addition, significant associations were found between ΔMD and YKL40xAGE (tail of left hippocampus and surrounding areas and right anterior cingulate gyrus) and sTREM2xAGE (right superior temporal gyrus). Areas showing statistically significant differences were disjoint in analyses involving YKL40 and sTREM2. These results suggest that glial biomarkers exert a relevant and distinct influence in longitudinal brain macro- and microstructural changes in cognitively unimpaired adults, which appears to be modulated by age. In younger subjects increased glial markers (both YKL40 and sTREM2) predict a better outcome, as indicated by a decrease in ΔGM and ΔWM and an increase in ΔMD, whereas in older subjects this association is inverted and higher levels of glial markers are associated with a poorer neuroimaging outcome.

摘要

脑脊液 (CSF) YKL40 和 sTREM2 分别是星形胶质细胞和小胶质细胞活性的生物标志物。我们评估了认知正常成年人的脑脊液 YKL40 和 sTREM2 基线水平是否与纵向脑容量和弥散变化相关。在 2 年的时间间隔内,对 36 名参与者(57 至 78 岁,12 名男性)进行了两次脑 MRI 扫描。在基线时测定 CSF 中 Aβ、p-tau、YKL40 和 sTREM2 的浓度。我们通过纵向配对登记计算了每年的灰质和白质体积变化图(分别为ΔGM 和 ΔWM),并通过减法计算了每年的平均弥散度变化(ΔMD)。我们检查了 GM 和 WM 体积变化(ΔGM 和 ΔWM)与 YKL40 和 sTREM2 基线 CSF 水平之间的关联,并验证了这些关联在多大程度上受到年龄的调节(YKL40xAGE 和 sTREM2xAGE 相互作用)。我们发现左侧顶下小叶区域 GM 与 YKL40 之间存在正相关,而 sTREM2 与 GM 之间不存在相关性。还观察到 GM 与 YKL40xAGE(双侧额区、左楔前叶和左中央后回和缘上回)和 sTREM2xAGE(双侧颞叶和额叶皮层、壳核和左扣带中回)之间的负相关。我们发现 WM 与 YKL40xAGE(双侧上纵束)和 sTREM2xAGE(双侧上纵束、左上放射冠、后放射冠和内囊小趾、其他区域)之间存在负相关,但 WM 与 YKL40 或 sTREM2 之间不存在负相关。MD 与右眶区的 YKL40 呈正相关,与左舌回和楔前叶的 sTREM2 呈负相关。此外,还发现 MD 与 YKL40xAGE(左海马尾部及周围区域和右前扣带回)和 sTREM2xAGE(右颞上回)之间存在显著关联。在涉及 YKL40 和 sTREM2 的分析中,显示统计学差异的区域是不相交的。这些结果表明,神经胶质标志物在认知正常成年人的纵向脑宏观和微观结构变化中发挥了相关且独特的影响,这种影响似乎受到年龄的调节。在年轻受试者中,较高的神经胶质标志物(YKL40 和 sTREM2 )预示着更好的结果,表现为 GM 和 WM 的减少以及 MD 的增加,而在老年受试者中,这种关联相反,较高的神经胶质标志物与较差的神经影像学结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/c35f79c7acf3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/22caeefe3895/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/d62dfaedac37/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/c35f79c7acf3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/22caeefe3895/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/d62dfaedac37/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1339/6458453/c35f79c7acf3/gr3.jpg

相似文献

1
CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals.脑脊液神经胶质生物标志物 YKL40 和 sTREM2 与认知正常个体的纵向体积和弥散度变化相关。
Neuroimage Clin. 2019;23:101801. doi: 10.1016/j.nicl.2019.101801. Epub 2019 Apr 1.
2
Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.脑脊髓液 sTREM2 与早、晚期阿尔茨海默病的脑结构损伤速度呈矛盾关联。
J Alzheimers Dis. 2022;88(1):117-126. doi: 10.3233/JAD-220102.
3
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.脑脊液中的可溶性触发受体表达分子2(sTREM2)和 Tau 蛋白共同作用可预测老年人颞叶萎缩增加。
Cereb Cortex. 2020 Apr 14;30(4):2295-2306. doi: 10.1093/cercor/bhz240.
4
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
5
Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.脑脊髓液 sTREM2 水平与早期阿尔茨海默病的灰质体积增加和弥散度降低有关。
Alzheimers Dement. 2016 Dec;12(12):1259-1272. doi: 10.1016/j.jalz.2016.06.005. Epub 2016 Jul 14.
6
Glial activation and inflammation along the Alzheimer's disease continuum.沿阿尔茨海默病发展进程中的神经胶质细胞激活与炎症。
J Neuroinflammation. 2019 Feb 21;16(1):46. doi: 10.1186/s12974-019-1399-2.
7
Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.纵向基底前脑退化与阿尔茨海默病前症状期的 TREM2/C3 炎症生物标志物相互作用。
J Neurosci. 2020 Feb 26;40(9):1931-1942. doi: 10.1523/JNEUROSCI.1184-19.2019. Epub 2020 Jan 8.
8
Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.临床前阿尔茨海默病患者脑脊液 sTREM2 的动态变化:CABLE 研究。
Mol Neurodegener. 2020 Apr 10;15(1):25. doi: 10.1186/s13024-020-00374-8.
9
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease.路易体痴呆与阿尔茨海默病患者脑脊液神经胶质标志物的不同模式。
Sci Rep. 2019 May 24;9(1):7803. doi: 10.1038/s41598-019-44173-8.
10
Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.阿尔茨海默病患者脑脊液 sTREM2 与淀粉样蛋白和 tau 病理相关,但与认知状态无关。
J Alzheimers Dis. 2022;90(3):1123-1138. doi: 10.3233/JAD-220598.

引用本文的文献

1
Longitudinal association of shorter leukocyte telomere length with CSF biomarker dynamics across early Alzheimer's disease stages in at-risk individuals.在有风险个体的早期阿尔茨海默病阶段,较短的白细胞端粒长度与脑脊液生物标志物动态变化的纵向关联。
EBioMedicine. 2025 Aug 19;119:105886. doi: 10.1016/j.ebiom.2025.105886.
2
TREM2 in MASH: integrating lipid metabolism and immune response.MASH中的TREM2:整合脂质代谢与免疫反应
Front Immunol. 2025 Jun 25;16:1604837. doi: 10.3389/fimmu.2025.1604837. eCollection 2025.
3
Emerging Microglial Therapies and Targets in Clinical Trial.

本文引用的文献

1
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
2
What can DTI tell about early cognitive impairment? - Differentiation between MCI subtypes and healthy controls by diffusion tensor imaging.DTI 能告诉我们早期认知障碍的什么信息?——通过弥散张量成像对 MCI 亚型与健康对照进行区分。
Psychiatry Res Neuroimaging. 2018 Feb 28;272:46-57. doi: 10.1016/j.pscychresns.2017.10.007. Epub 2017 Oct 31.
3
临床试验中的新兴小胶质细胞治疗方法和靶点
Adv Neurobiol. 2024;37:623-637. doi: 10.1007/978-3-031-55529-9_35.
4
CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease.脑脊液神经胶质生物标志物与阿尔茨海默病风险个体的认知功能有关。
Alzheimers Dement. 2024 Sep;20(9):5819-5832. doi: 10.1002/alz.13862. Epub 2024 Jul 19.
5
Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer's Disease.胶质母细胞瘤和阿尔茨海默病中与小胶质细胞/巨噬细胞相关的途径的比较研究。
Int J Mol Sci. 2023 Dec 19;25(1):16. doi: 10.3390/ijms25010016.
6
Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study.阿尔茨海默病和其他神经退行性疾病中的炎症与大脑结构:一项孟德尔随机研究。
Mol Neurobiol. 2024 Mar;61(3):1593-1604. doi: 10.1007/s12035-023-03648-6. Epub 2023 Sep 22.
7
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease.液体生物标志物在阿尔茨海默病诊断和治疗靶点中的研究进展与应用
CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.
8
Conserved YKL-40 changes in mice and humans after postoperative delirium.术后谵妄后小鼠和人类中YKL-40的保守变化。
Brain Behav Immun Health. 2022 Nov 17;26:100555. doi: 10.1016/j.bbih.2022.100555. eCollection 2022 Dec.
9
Multisystem physiological perspective of human frailty and its modulation by physical activity.人体脆弱性的多系统生理观点及其通过身体活动的调节。
Physiol Rev. 2023 Apr 1;103(2):1137-1191. doi: 10.1152/physrev.00037.2021. Epub 2022 Oct 14.
10
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.早期阿尔茨海默病连续体中伴有淀粉样蛋白-β、tau蛋白、神经胶质和神经退行性变脑脊液标志物的脑改变。
Brain Commun. 2022 May 24;4(3):fcac134. doi: 10.1093/braincomms/fcac134. eCollection 2022.
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.
中老年人群纵向白质变性与神经退行性变、炎症和阿尔茨海默病的脑脊液生物标志物的相关性研究。
Brain Imaging Behav. 2019 Feb;13(1):41-52. doi: 10.1007/s11682-017-9732-9.
4
The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.导致TREM2 T66M突变的额颞叶痴呆样综合征会损害小胶质细胞功能、脑灌注和葡萄糖代谢。
EMBO J. 2017 Jul 3;36(13):1837-1853. doi: 10.15252/embj.201796516. Epub 2017 May 30.
5
Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.衰老大脑中的炎症、淀粉样蛋白和萎缩:与认知纵向变化的关系
J Alzheimers Dis. 2017;58(3):829-840. doi: 10.3233/JAD-161146.
6
TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.TREM2缺陷会损害趋化作用以及小胶质细胞对神经元损伤的反应。
EMBO Rep. 2017 Jul;18(7):1186-1198. doi: 10.15252/embr.201743922. Epub 2017 May 8.
7
Elucidating the Role of TREM2 in Alzheimer's Disease.阐明 TREM2 在阿尔茨海默病中的作用。
Neuron. 2017 Apr 19;94(2):237-248. doi: 10.1016/j.neuron.2017.02.042.
8
The ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.ε4基因型在阿尔茨海默病连续过程中调节脑脊液YKL-40水平及其与脑结构的相关性,但不调节sTREM2的水平及相关性。
Alzheimers Dement (Amst). 2016 Dec 22;6:50-59. doi: 10.1016/j.dadm.2016.12.002. eCollection 2017.
9
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.在显性遗传性阿尔茨海默病中,CSF sTREM2 的早期变化发生在淀粉样蛋白沉积和神经元损伤之后。
Sci Transl Med. 2016 Dec 14;8(369):369ra178. doi: 10.1126/scitranslmed.aag1767.
10
Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.脑脊髓液 sTREM2 水平与早期阿尔茨海默病的灰质体积增加和弥散度降低有关。
Alzheimers Dement. 2016 Dec;12(12):1259-1272. doi: 10.1016/j.jalz.2016.06.005. Epub 2016 Jul 14.